Neurostimulation techniques in the treatment of nicotine dependence: A review

American Journal on Addictions

Volumn 25, Issue 6, 2016, Pages 436-451

  Rachid, Fady ^a  

^a Private Practice   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE;

BRAIN DEPTH STIMULATION; CLINICAL EFFECTIVENESS; CONTROLLED CLINICAL TRIAL (TOPIC); CRANIAL ELECTROSTIMULATION; DEEP TRANSCRANIAL MAGNETIC STIMULATION; ELECTROCONVULSIVE THERAPY; HUMAN; MAGNETIC SEIZURE THERAPY; NERVE STIMULATION; PATIENT SAFETY; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION; REVIEW; SCHIZOPHRENIA; THETA BURST STIMULATION; TOBACCO CONSUMPTION; TOBACCO DEPENDENCE; TRANSCRANIAL DIRECT CURRENT STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84983467777     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1111/ajad.12405     Document Type: Review

References (112)

1. WHO. Warning about the dangers of tobacco. WHO Library Cataloguing-In-Publication Data. WHO report on the global tobacco epidemic 2011.
2. Hughes JR. Effects of abstinence from tobacco: Valid symptoms and time course. Nicotine Tob Res. 2007; 9:315–327.
3. Siu EC, Tyndale RF. Non-nicotinic therapies for smoking cessation. Annu Rev Pharmacol Toxicol. 2007; 47:541–564.
4. Alkondon M, Pereira EF, Barbosa CT, et al. Neuronal nicotinic acetylcholine receptor activation modulates gamma-aminobutyric acid release from CA1 neurons of rat hippocampal slices. J Pharmacol Exp Ther. 1997; 283:1396–1411.
5. Westfall TC, Grant H, Perry H. Release of dopamine and 5-hydroxytryptamine from rat striatal slices following activation of nicotinic cholinergic receptors. Gen Pharmacol. 1983; 14:321–325.
6. Poorthuis RB, Goriounova NA, Couey JJ, et al. Nicotinic actions on neuronal networks for cognition: General principles and long-term consequences. Biochem Pharmacol. 2009; 78:668–676.
7. Changeux JP, Bertrand D, Corringer PJ, et al. Brain nicotinic receptors: Structure and regulation, role in learning and reinforcement. Brain Res Brain Res Rev. 1998; 26(2e3):198e216.
8. Wonnacott S, Irons J, Rapier C, et al. Presynaptic modulation of transmitter release by nicotinic receptors. Prog Brain Res. 1989; 79:157e63.
9. Di Chiara G. Role of dopamine in the behavioural actions of nicotine related to addiction. Eur J Pharmacol. 2000; 393(1e3):295e314.
10. Volkow ND, Li TK. Drug addiction: The neurobiology of behaviour gone awry. Nat Rev Neurosci. 2004; 5:963e70.
11. Koob GF. The neurobiology of addiction: A neuroadaptational view relevant for diagnosis. Addiction. 2006; 101(Suppl. 1):23e30.
12. Domino EF, Minoshima S, Guthrie S, et al. Nicotine effects on regional cerebral blood flow in awake, resting tobacco smokers. Synapse. 2000; 3:313–321.
13. Zubieta J, Lombardi U, Minoshima S, et al. Regional cerebral blood flow effects of nicotine in overnight abstinent smokers. Biol Psychiatry. 2001; 49:906–913.
14. Brody AL, Mandelkern MA, London ED, et al. Brain metabolic changes during cigarette craving. Arch Gen Psychiatry. 2002; 59:1162–1172.
15. McBride D, Barrett SP, Kelly JT, et al. Effects of expectancy and abstinence on the neural response to smoking cues in cigarette smokers: An fMRI study. Neuropsychopharmacology. 2006; 31:2728–2738.
16. Lee JH, Lim Y, Wiederhold BK, et al. A functional magnetic resonance imaging (FMRI) study of cue-induced smoking craving in virtual environments. Appl Psychophysiol Biofeedback. 2005; 30:195–204.
17. Talati A, Hirsch J. Functional specialization within the medial frontal gyrus for perceptual go/no-go decisions based on “what,” “when,” and “where” related information: An fMRI study. J Cogn Neurosci. 2005; 17:981–993.
18. Brody AL, Mandelkern MA, Lee G, et al. Attenuation of cue induced cigarette craving and anterior cingulate cortex activation in bupropion-treated smokers: A preliminary study. Psychiatry Res. 2004; 130:269–281.
19. Gallinat J, Meisenzahl E, Jacobsen LK, et al. Smoking and structural brain deficits: A volumetric MR investigation. Eur J Neurosci. 2006; 24:1744–1750.
20. Naqvi NH, Gaznick N, Tranel D, et al. The insula: A critical neural substrate for craving and drug seeking under conflict and risk. Ann N Y Acad Sci. 2014; 1316:53–70.
21. Wagner T, Valero-Cabre A, Pascual-Leone A. Noninvasive human brain stimulation. Annu Rev Biomed Eng. 2007; 9:527–565.
22. Hallett M. Transcranial magnetic stimulation: A primer. Neuron. 2007; 55:187–199.
23. Wassermann EM, Lisanby SH. Therapeutic application of repetitive transcranial magnetic stimulation: A review. Clin Neurophysiol. 2001; 112:1367–1377.
24. Rachid F, Bertschy G. Safety and efficacy of repetitive transcranial magnetic stimulation in the treatment of depression: A critical appraisal of the last 10 years. Clin Neurophysiol. 2006; 36:157–183.
25. Daskalakis ZJ, Moller B, Christensen BK, et al. The effects of repetitive transcranial magnetic stimulation on cortical inhibition in healthy human subjects. Exp Brain Res. 2006; 174:403–412.
26. Fitzgerald PB, Fountain S, Daskalakis ZJ. A comprehensive review of the effects of rTMS on motor cortical excitability and inhibition. Clin Neurophysiol. 2006; 117:2584–2596.
27. Roth Y, Zangen A, Hallett M. A coil design for transcranial magnetic stimulation of deep brain regions. J Clin Neurophysiol. 2002; 19:361–370.
28. Roth Y, Amir A, Levkovitz Y, et al. Three-dimensional distribution of the electric field induced in the brain by transcranial magnetic stimulation using figure-8 and deep H-coils. J Clin Neurophysiol. 2007; 24:31–38.
29. Levkovitz Y, Roth Y, Harel EV, et al. A randomized controlled feasibility and safety study of deep transcranial magnetic stimulation. Clin Neurophysiol. 2007; 118:2730–2744.
30. Di Lazzaro V, Dileone M, Pilato F, et al. Modulation of motor cortex neuronal networks by rTMS: comparison of local and remote effects of six different protocols of stimulation. J Neurophysiol. 2011; 105:2150–2156.
31. Rossi S, Hallett M, Rossini PM, et al. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol. 2009; 120:2008–2039.
32. Loo CK, McFarquhar TF, Mitchell PB. A review of the safety of repetitive transcranial magnetic stimulation as a clinical treatment for depression. Int J Neuropsychopharmacology. 2008; 11:131–147.
33. UK ECT Review Group: Efficacy and safety of electroconvulsive therapy in depressive disorders: A systematic review and meta-analysis. Lancet. 2003; 361:799–808.
34. Kosel M, Frick C, Lisanby SH, et al. Magnetic seizure therapy improves mood in refractory major depression. Neuropsychopharmacology. 2003; 28:1889–1902.
35. Nitsche MA, Paulus W. Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation. J Physiol Lond. 2000; 527(Pt. 3):633–639.
36. Nitsche MA, Cohen LG, Wassermann EM, et al. Transcranial direct current stimulation: State of the art 2008. Brain Stimul. 2008; 1:206e23.
37. Nitsche MA, Nitsche MS, Klein CC, et al. Level of action of cathodal DC polarisation induced inhibition of the human motor cortex. Clin Neurophysiol. 2003; 114:600–604.
38. Priori A. Brain polarization in humans: A reappraisal of an old tool for prolonged noninvasive modulation of brain excitability. Clin Neurophysiol. 2003; 114:589–595.
39. Bindman LJ, Lippold OC, Redfearn JW. The Action of brief polarizing currents on the cerebral cortex of the rat (1) during current flow and (2) in the production of long-lasting after-effects. J Physiol Lond. 1964; 172:369–382.
40. Liebetanz D, Nitsche MA, Tergau F, et al. Pharmacological approach to the mechanisms of transcranial DC-stimulation-induced after-effects of human motor cortex excitability. Brain. 2002; 125:2238–2247.
41. Stagg CJ, Nitsche MA. Physiological basis of transcranial direct current stimulation. Neuroscientist. 2011; 17:37–53.
42. Monte-Silva K, Kuo MF, Hessenthaler S, et al. Induction of late LTP-like plasticity in the human motor cortex by repeated non-invasive brain stimulation. Brain Stimul. 2013; 6:424–432.
43. Shealey C, Cady R, Wilkie R, et al. Depression: A diagnostic, neurochemical profile and therapy with cranial electrical stimulation (CES). J Neurol Orthop Med Surg. 1989; 10:319–321.
44. Gilula MF. Cranial electrotherapy stimulation and fibromyalgia. Expert Rev Med Devices. 2007; 4:489–495.
45. Schlaepfer TE, Lieb K. Deep brain stimulation for treatment of refractory depression. Lancet. 2005; 366:1420–1422.
46. Schlaepfer TE, Bewernick BH. Deep brain stimulation for psychiatric disorders—State of the art. Adv Tech Stand Neurosurg. 2009; 34:37–57.
47. Johann M, Wiegand R, Kharraz A, et al. Repetitive transcranial magnetic stimulation in nicotine dependence. Psychiatrische Prax. 2003; 30:S129–S131.
48. Eichhammer P, Johann M, Kharraz A, et al. High-frequency repetitive transcranial magnetic stimulation decreases cigarette smoking. J Clin Psychiatry. 2003; 64:951–953.
49. Amiaz R, Levy D, Vainiger D, et al. Repeated high-frequency transcranial magnetic stimulation over the dorsolateral prefrontal cortex reduces cigarette craving and consumption. Addiction. 2009; 104:653–660.
50. Li X, Hartwell KJ, Owens M, et al. Repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex reduces nicotine cue craving. Biol Psychiatry. 2013; 73:714–720.
51. Rose JE, McClernon FJ, Froeliger B, et al. Repetitive transcranial magnetic stimulation of the superior frontal gyrus modulates craving for cigarettes. Biol Psychiatry. 2011; 70:794–799.
52. McClernon FJ, Hiott FB, Huettel SA, et al. Abstinence-induced changes in self-report craving correlate with event-related FMRI responses to smoking cues. Neuropsychopharmacology. 2005; 30:1940–1947.
53. McClernon FJ, Kozink RV, Lutz AM, et al. 24-h smoking abstinence potentiates fMRIBOLD activation to smoking cues in cerebral cortex and dorsal striatum. Psychopharmacology (Berl). 2009; 204:25–35.
54. Sheffer CE, Mennemeier M, Landes RD, et al. Neuromodulation of delay discounting, the reflection effect, and cigarette consumption. J Subst Abuse Treat. 2013; 45:206–214.
55. Pripfl J, Tomova L, Riecansky I, et al. Transcranial magnetic stimulation of the left dorsolateral prefrontal cortex decreases cue-induced nicotine craving and EEG delta power. Brain Stimul. 2014; 7:226–233.
56. Trojak B, Meille V, Achab S, et al. Transcranial magnetic stimulation combined with nicotine replacement therapy for smoking cessation: A randomized controlled trial. Brain Stimul. 2015; 8:1168–1174.
57. Wing VC, Wass CE, Soh DW, et al. A review of neurobiological vulnerability factors and treatment implications for comorbid tobacco dependence in schizophrenia. Ann N Y Acad Sci. 2012; 248:89–106.
58. Prikryl R, Ustohal L, Kucerova HP, et al. Repetitive transcranial magnetic stimulation reduces cigarette consumption in schizophrenia patients. Prog Neuropsychopharmacol Biol Psychiatry. 2014; 49:30–35.
59. Dieler AC, Dresler T, Joachim K, et al. Can intermittent theta burst stimulation as add-on to psychotherapy improve nicotine abstinence? Results from a pilot study. Eur Addict Res. 2014; 20:248–253.
60. Dinur-Klein L, Dannon P, Hadar A, et al. Smoking cessation induced by deep repetitive transcranial magnetic stimulation of the prefrontal and insular cortices: A prospective, randomized controlled trial. Biol Psychiatry. 2014; 76:742–749.
61. Fregni F, Liguori P, Fecteau S, et al. Cortical stimulation of the prefrontal cortex with transcranial direct current stimulation reduces cue provoked smoking craving: A randomized, sham-controlled study. J Clin Psychiatry. 2008; 69:32–40.
62. Boggio PS, Liguori P, Sultani N, et al. Cumulative priming effects of cortical stimulation on smoking cue-induced craving. Neurosci Lett. 2009; 463:82e6.
63. Xu J, Fregni F, Brody AL, et al. Transcranial direct current stimulation reduces negative affect but not cigarette craving in overnight abstinent smokers. Front Psychiatry. 2013; 4:112.
64. Fecteau S, Agosta S, Hone-Blanchet A, et al. Modulation of smoking and decision-making behaviors with transcranial direct current stimulation in tobacco smokers: A preliminary study. Drug Alcohol Depend. 2014; 140:78–84.
65. Meng Z, Liu C, Yu C, et al. Transcranial direct current stimulation of the frontal-parietal-temporal area attenuates smoking behavior. J Psychiatr Res. 2014; 54:19–25.
66. Falcone M, Bernardo L, Ashare RL, et al. Transcranial direct current brain stimulation increases ability to resist smoking. Brain Stimul. 2015;pii: S1935-861X(15) 01214-0.
67. Smith RC, Boules S, Mattiuz S, et al. Effects of transcranial direct current stimulation (tDCS) on cognition, symptoms, and smoking in schizophrenia: A randomized controlled study. Schizophr Res. 2015; 168:260–266.
68. Patterson MA, Firth J, Gardiner R. Treatment of drug, alcohol and nicotine addiction by neuroelectric therapy: Analysis of results over 7 years. J Bioelectricity. 1984; 3:193e221.
69. Pickworth WB, Fant RV, Butschky MF, et al. Evaluation of cranial electrostimulation therapy on short-term smoking cessation. Biol Psychiatry. 1997; 42:116–121.
70. Georgiou AJ, Spencer CP, Davies GK, et al. Electrical stimulation therapy in the treatment of cigarette smoking. J Subst Abuse. 1998; 10:265e74.
71. Kuhn J, Bauer R, Pohl S, et al. Observations on unaided smoking cessation after deep brain stimulation of the nucleus accumbens. Eur Addict Res. 2009; 15:196–201.
72. Mantione M, van de Brink W, Schuurman PR, et al. Smoking cessation and weight loss after chronic deep brain stimulation of the nucleus accumbens: Therapeutic and research implications: Case report. Neurosurgery. 2010; 66:E218.
73. Bauer R, Pohl S, Klosterkotter J, et al. Deep brain stimulation in the context of addiction—A literature-based systematic evaluation. Fortschr Neurol Psychiatr. 2008; 76:396–401.
74. Feil J, Zangen A. Brain stimulation in the study and treatment of addiction. Neurosci Biobehav Rev. 2010; 34:559–574.
75. Barr MS, Farzan F, Wing VC, et al. Repetitive transcranial magnetic stimulation and drug addiction. Int Rev Psychiatry. 2011; 23:454–466.
76. Luigjes J, Breteler R, Vanneste S, et al. Neuromodulation as an intervention for addiction: Overview and future prospects. Tijdschr Psychiatr. 2013; 55:841–852.
77. De Sousa A. Repetitive transcranial magnetic stimulation (rTMS) in the management of alcohol dependence and other substance abuse disorders—Emerging data and clinical relevance. Basic Clin Neurosci. 2013; 4:271–275.
78. Wing VC, Barr MS, Wass CE, et al. Brain stimulation methods to treat tobacco addiction. Brain Stimul. 2013; 6:221–230.
79. Gorelick DA, Zangen A, George MS. Transcranial magnetic stimulation in the treatment of substance addiction. Ann N Y Acad Sci. 2014; 1327:79–93.
80. Bellamoli E, Manganotti P, Schwartz RP, et al. RTMS in the treatment of drug Addiction: An Update about human studies. Behav Neurol. 2014; 2014:815215.
81. Goodman A. Neurobiology of addiction. An integrative review. Biochem Pharmacol. 2008; 75:266–322.
82. Pascual-Leone A, Valls-Sole J, Wassermann EM, et al. Responses to rapid-rate transcranial magnetic stimulation of the human motor cortex. Brain. 1994; 117:847–858.
83. Strafella AP, Paus T, Barrett J, et al. Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus. J Neurosci. 2001; 21:RC157.
84. Pogarell O, Koch W, Popperl G, et al. Striatal dopamine release after prefrontal repetitive transcranial magnetic stimulation in major depression: Preliminary results of a dynamic [123I] IBZM SPECT study. J Psychiatr Res. 2006; 40:307–314.
85. Mathieu-Kia AM, Kellogg SH, Butelman ER, et al. Nicotine addiction: Insights from recent animal studies. Psychopharmacology (Berl). 2002; 162:102–118.
86. Naqvi NH, Bechara A. The insula and drug addiction: An interoceptive view of pleasure, urges, and decision-making. Brain Structure Function. 2010; 214:435e50.
87. Naqvi NH, Rudrauf D, Damasio H, et al. Damage to the insula disrupts addiction to cigarette smoking. Science. 2007; 315:531e4.
88. Goldstein RZ, Volkow ND, Wang GJ, et al. Addiction changes orbitofrontal gyrus function: Involvement in response inhibition. Neuroreport. 2001; 12:2595–2599.
89. Goldstein RZ, Volkow ND. Drug addiction and its underlying neurobiological basis: Neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry. 2002; 159:1642–1652.
90. Diana M. The dopamine hypothesis of drug addiction and its potential therapeutic value. Front Psychiatry. 2011; 2:64.
91. Hayashi T, Ko JH, Strafella AP, et al. Dorsolateral prefrontal and orbitofrontal cortex interactions during self-control of cigarette craving. Proc Natl Acad Sci USA. 2013; 110:4422–4427.
92. McBride D, Barrett SP, Kelly JT, et al. Effects of expectancy and abstinence on the neural response to smoking cues in cigarette smokers: An fMRI study. Neuropsychopharmacology. 2006; 31:2728e38.
93. Wilson SJ, Sayette MA, Fiez JA. Prefrontal responses to drug cues: A neurocognitive analysis. Nature Neuroscience. 2004; 7:211e4.
94. Pripfl J, Neumann R, Kohler U, et al. Effects of transcranial direct current stimulation on risky decision making are mediated by ‘hot’ and ‘cold’ decisions, personality, and hemisphere. Eur J Neurosci. 2013; 38:3778–3785.
95. Berardelli A, Inghilleri M, Rothwell JC, et al. Facilitation of muscle evoked responses after repetitive cortical stimulation in man. Exp Brain Res. 1998; 122:79–84.
96. Pascual-Leone A, Valls-Sole J, Hallett M, et al. Responses to rapid-rate transcranial magnetic stimulation of the human motor cortex. Brain. 1994; 117:847–858.
97. Cooke FS, Bliss TV. Plasticity in the human central nervous system. Brain. 2006; 129:1659–1673.
98. Huang YZ, Edwards MJ, Rounis E, et al. Theta burst stimulation of the human motor cortex. Neuron. 2005; 45:201–206.
99. Heatherton TF, Kozlowski LT, Frecker RC, et al. The fagerstrom test for nicotine dependence: A revision of the fagerstrom tolerance questionnaire. Br J Addict. 1991; 86:1119–1127.
100. Heishman SJ, Singleton EG, Moolchan ET. Tobacco craving questionnaire: Reliability and validity of a new multifactorial instrument. Nicotine Tob Res. 2003; 5:645–654.
101. Cox LS, Tiffany ST, Christen AG. Evaluation of the brief questionnaire of smoking urges (QSU brief) in laboratory and clinical settings. Nicotine Tob Res. 2001; 3:7–16.
102. Weinberger AH, Reutenauer EL, Allen TM, et al. The reliability and internal consistency of the fagertsrom test for nicotine dependence, minnesota nicotine withdrawal scale and tiffany questionnaire for smoking urges in cigarette smokers with and without schizophrenia. Drug Alcohol Depend. 2007; 86:278–282.
103. Shiffman SM, Jarvik ME. Smoking withdrawal symptoms in two weeks of abstinence. Psychopharmacology. 1976; 50:35–39.
104. Cappelleri JC, Bushmakin AG, Baker CL, et al. Confirmatory factor analyses and reliability of the modified cigarette evaluation questionnaire. Addict Behav. 2007; 32:912–923.
105. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987; 13:261–276.
106. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979; 134:382–389.
107. Addington D, Addington J, Maticka-Tyndale E, et al. Reliability and validity of a depression rating scale for schizophrenics. Schizophr Res. 1992; 6:201–208.
108. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961; 4:561–571.
109. Pollock V, Cho DW, Reker D, et al. Profile of mood states: The factors and their physiological correlates. J Nerv Ment Dis. 1979; 167:612–614.
110. Morgan MJ, Davies GM, Willner P. The questionnaire of smoking urges is sensitive to abstinence and exposure to smoking-related cues. Behav Pharmacol. 1999; 10:619–626.
111. Jenkins RL, Stauffacher J, Hester R. A symptom rating scale for use with psychotic patients. AMA Arch Gen Psychiatry. 1959; 1:197–204.
112. Marder SR, Fenton WS. Measurement and treatment research to improve cognition in schizophrenia: NIMH MATRICS Initiative to support the development of agents for improving cognition in schizophrenia. Schizophr Res. 2004; 72:5–9.